Yahoo Canada Web Search

Search results

  1. Jan 5, 2012 · The use of music therapy in the integrative treatment of cancer patients is a therapeutic option whose salutogenetic potential is shown in many case studies such as those presented here. Study results, however, did not draw a conclusive picture of the overall effect of music therapy.

  2. The purpose of this paper is to show some aspects of music therapy application in cancer care and to present the integration of music therapy program into a continuous supportive cancer care for inpatients.

  3. Jul 11, 2023 · Music has been used as an effective therapeutic tool for helping patients to improve, restore, or maintain health. 15,16 Music has been shown to have positive effects on physical (ie, pain and fatigue) as well as psychological (ie, mood and quality of life) outcomes during cancer treatment. 11,12,17 Given that patients receiving chemotherapy ...

  4. Sep 1, 2011 · The purpose of this paper is to show some aspects of music therapy application in cancer care and to present the integration of music therapy program into a continuous supportive cancer care for inpatients.

    • Malgorzata Monika Stanczyk
    • 2011
  5. Apr 16, 2020 · Introduction: Music therapy is used as an adjunct oncological treatment aiming at the improvement of psychological and physical well-being through music. A growing body of randomized and non-randomized controlled trials has been published and reviewed recently.

    • Friederike Köhler, Friederike Köhler, Zoe-Sofia Martin, Ruth-Susanne Hertrampf, Christine Gäbel, Chr...
    • 2020
  6. Oct 12, 2021 · Music interventions have been used to alleviate symptoms and treatment side effects in people with cancer. This review includes music interventions defined as music therapy offered by trained music therapists, as well as music medicine, which was defined as listening to pre-recorded music offered by medical staff.

  7. People also ask

  8. Dec 12, 2022 · Music therapy (MT) has been shown to improve outcomes for patients with sickle cell disease (SCD) and patients with hematologic and/or oncologic conditions excluding SCD (HemOnc) in prior randomized trials.